000 | 01208 a2200289 4500 | ||
---|---|---|---|
005 | 20250514162236.0 | ||
264 | 0 | _c20040805 | |
008 | 200408s 0 0 eng d | ||
022 | _a0929-5305 | ||
024 | 7 |
_a10.1023/b:thro.0000003309.34726.b4 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVerheugt, Freek W A | |
245 | 0 | 0 |
_aGlycoprotein IIb/IIIa blockers in non-ST elevation acute coronary syndromes: only for well defined subgroups or a therapeutic option for all patients? _h[electronic resource] |
260 |
_bJournal of thrombosis and thrombolysis _cApr 2003 |
||
300 |
_a81-4 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAcute Disease |
650 | 0 | 4 | _aContraindications |
650 | 0 | 4 |
_aCoronary Disease _xdrug therapy |
650 | 0 | 4 | _aElectrocardiography |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors |
650 | 0 | 4 | _aPractice Guidelines as Topic |
773 | 0 |
_tJournal of thrombosis and thrombolysis _gvol. 15 _gno. 2 _gp. 81-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1023/b:thro.0000003309.34726.b4 _zAvailable from publisher's website |
999 |
_c14354985 _d14354985 |